Olema Pharmaceuticals, Inc.
OLMA • NASDAQ
Olema Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sean Bohen, with a market cap of $1.2B.
CEOSean Bohen
Next Earnings
Upcoming earnings announcement for Olema Pharmaceuticals, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.53
Earnings History
Past 12 earnings reports for Olema Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Q4 2025 | -$0.50Est: -$0.52 | +3.8% | - | — |  10-K |
| Nov 10, 2025 | Q3 2025 | -$0.49Est: -$0.44 | -11.4% | - | — | 10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.51Est: -$0.43 | -18.6% | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.36Est: -$0.50 | +28.0% | - | — | 10-Q |
| Mar 18, 2025 | Q4 2024 | -$0.51Est: $0.17 | -400.0% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.60Est: -$0.57 | -5.3% | - | — | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.54Est: -$0.55 | +1.8% | - | — | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.56Est: -$0.51 | -9.8% | - | — | 10-Q |
| Mar 11, 2024 | Q4 2023 | -$0.49Est: -$0.48 | -2.1% | - | — | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.48Est: -$0.51 | +5.9% | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$0.49Est: -$0.73 | +32.9% | - | — | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.70Est: -$0.66 | -6.1% | - | — | — |